Dear Shareholders,
The third quarter of 2001 brought exciting developments for SHL Telemedicine Ltd. in the European market, supported by a particularly good performance at home and FDA approval for the Telepress III remote blood-pressure monitor. The opening of Philips HeartCare Telemedicine Services' first European medical call center in
Zurich represents an important milestone following SHL's entry to the European equity markets last year via an IPO on the SWX New Market.
Download the
full report